A detailed history of Jump Financial, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 42,200 shares of DCTH stock, worth $491,208. This represents 0.01% of its overall portfolio holdings.

Number of Shares
42,200
Previous 32,200 31.06%
Holding current value
$491,208
Previous $269,000 41.64%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.36 - $11.0 $73,600 - $110,000
10,000 Added 31.06%
42,200 $381,000
Q2 2024

Aug 14, 2024

BUY
$4.47 - $8.37 $143,934 - $269,514
32,200 New
32,200 $269,000

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $100M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.